|
Jul 30
|
Formycon Invites to Conference Call on 2025 Half-year Results and Announces Participation in International Investor Conferences in the 3rd Quarter of 2025
|
|
Jul 28
|
European Growth Companies With High Insider Ownership July 2025
|
|
Jul 28
|
High Growth Tech Stocks in Europe for July 2025
|
|
Jun 18
|
Ordinary Annual General Meeting of Formycon AG Approves all Proposed Resolutions by Large Majorities
|
|
May 28
|
High Growth Tech Stocks in Europe for May 2025
|
|
May 28
|
3 European Growth Stocks With Strong Insider Ownership
|
|
May 27
|
Fresenius Kabi to announce the commercial launch of Otulfi™*, an approved Ustekinumab Biosimilar in Canada
|